ChennaiJCI · NABH · NABL
7th Street, Dr. Vasi Estate, Phase II, Tharamani, Chennai

About
Apollo Proton Cancer Center (APCC), Chennai, is a specialized cancer hospital founded on a single central objective: providing advanced, comprehensive treatment for patients with complex and challenging cancers. Inaugurated in January 2019, the center became the first proton therapy facility in South Asia and the Middle East. It introduced proton therapy to India while building a broader cancer program that integrates surgery, systemic treatment and radiation oncology.
The center's major distinction is its multi-room proton therapy facility, complemented by advanced radiation therapy, robotic and conventional cancer surgery, chemotherapy, immunotherapy, targeted therapy, bone marrow transplantation, and other specialized oncology procedures. APCC uses organ-specific Cancer Management Teams, bringing together surgical oncologists, medical oncologists, radiation oncologists, genetics and pathology specialists to review individual cases.
For international patients, this multidisciplinary model can be particularly valuable when a case requires several treatment approaches or when patients are traveling to India for a second opinion. The center provides pre-arrival medical review, international coordination, visa assistance, airport support, interpreters, and post-treatment teleconsultation services.
Its 150-bed infrastructure includes clinical, research, and intensive-care capacity, allowing patients to receive specialized cancer treatment and access dedicated critical-care support when medically necessary.
Specialities
Awards & Accreditations
APCC became India's first dedicated advanced cancer center to receive JCI accreditation. The accreditation reflects compliance with internationally recognized standards for patient safety, clinical quality, and healthcare processes.
Apollo's accreditation records show APCC's latest JCI accreditation in 2023, demonstrating continued participation in international quality assessment rather than relying only on its original accreditation.
APCC received the national Hospital of the Year – Oncology award at the Economic Times Healthcare Awards 2025, recognizing its position within India's cancer-care landscape.
Apollo Proton Cancer Center was associated with this recognition at the International Hospital Federation Awards in 2023, highlighting attention to healthcare worker wellbeing and organizational excellence.
Medical Team
Complex cancer cases often require more than one treatment modality. APCC therefore uses multidisciplinary Cancer Management Teams, in which specialists from different fields review individual cases and coordinate treatment. The center's model brings together clinical expertise in surgical, medical, and radiation oncology, alongside pathology and genetics.
Infrastructure
APCC's proton facility is the centre's defining technology. Proton therapy can deliver radiation to selected tumors while potentially reducing dose beyond the target compared with conventional photon treatment.
The centre's proton platform supports advanced beam-delivery approaches designed to shape radiation around tumors with high precision for appropriately selected patients.
Provides multiple radiation techniques, including IMRT, IGRT, stereotactic radiotherapy, 3D conformal therapy and brachytherapy, allowing treatment to be selected according to tumor characteristics.
Robotic surgery supports selected minimally invasive cancer procedures where enhanced visualization and instrument control may be beneficial.
Provides a dedicated setting for patients receiving systemic cancer treatments who do not require overnight hospitalization.
Supports patients requiring hematopoietic stem-cell transplantation with specialized clinical monitoring and infection-control measures.
The centre has 40 ICU beds according to Apollo's published facility information, with specialized support for critically ill cancer patients.
Critical-care infrastructure includes positive- and negative-pressure isolation rooms designed to support infection prevention for vulnerable oncology patients.
PET-CT, PET-MRI, CT and MRI services support diagnosis, staging, treatment planning and follow-up assessment.
The centre includes dedicated research capacity alongside clinical beds, supporting its broader focus on cancer innovation and translational work.
Video
Gallery
Facilities
International Department
Apollo Proton Cancer Centre has developed dedicated international patient services for people traveling to Chennai from Asia, the Middle East, Africa, Central Asia, and other regions. Patients receive support from the International Patient Service team, which can coordinate appointments, medical records, travel, visa requirements, and other aspects of the treatment journey.
For an international patient traveling to India for cancer treatment, the process involves much more than booking a hospital appointment. APCC's international services are designed to coordinate the medical and practical aspects of the journey—from pre-arrival records and visa documentation to airport transfers, accommodations, interpretation, and post-treatment communication. This structured support can make the transition to treatment in Chennai easier for patients and their families.
Similar Hospitals
Chennai
Chennai
ChennaiNo. 7, CLC Works Road, Chromepet, Chennai
Chennai
Chennai2/473, 200 Feet Radial Road, Ganapathy Nagar, Kovilambakkam, Chennai
Chennai
Chennai
ChennaiFAQs
Yes. Apollo Proton Cancer Centre (APCC), Chennai, has dedicated international patient services for people travelling to India for cancer treatment. Support can include medical record coordination, consultations, visa assistance, airport transfers, accommodation guidance, interpreters, and follow-up services.
APCC is particularly known for its proton therapy program, which was the first of its kind in South Asia and the Middle East. The centre also combines proton therapy with medical oncology, surgical oncology, radiation oncology, robotic surgery, and other cancer services.
Proton therapy may be considered for selected cancers involving areas such as the brain, spine, head and neck, chest, abdomen, pelvis, and certain pediatric tumors. Suitability depends on the tumor's location, size, stage, previous treatment, and proximity to sensitive organs.
Yes. International patients can submit their medical records for preliminary evaluation. Biopsy reports, pathology slides or blocks, PET-CT/CT/MRI scans, previous treatment summaries, blood investigations, and molecular or genetic reports can help specialists assess the case.
Yes. International patients can explore online medical opinion before travelling to India. Which can help patients understand potential treatment options and determine what additional investigations may be required after arriving in Chennai.
Expert care is just a message away
Send your reports and Global Onco Care will help you plan doctor appointment, estimated cost, travel, and admission process.